.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Chinese Patent Office
Farmers Insurance
US Army
UBS
McKesson
US Department of Justice
Cantor Fitzgerald
QuintilesIMS

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021712

« Back to Dashboard
NDA 021712 describes FLUXID, which is a drug marketed by Ucb Inc and is included in one NDA. There are two patents protecting this drug. Additional details are available on the FLUXID profile page.

The generic ingredient in FLUXID is famotidine. There are eighteen drug master file entries for this compound. One hundred and twenty-three suppliers are listed for this compound. Additional details are available on the famotidine profile page.

Summary for 021712

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 021712

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, ORALLY DISINTEGRATING;ORALStrength20MG
Approval Date:Sep 24, 2004TE:RLD:No
Patent:► SubscribePatent Expiration:Apr 9, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Apr 9, 2018Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, ORALLY DISINTEGRATING;ORALStrength40MG
Approval Date:Sep 24, 2004TE:RLD:No
Patent:► SubscribePatent Expiration:Apr 9, 2018Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cerilliant
Merck
Harvard Business School
Colorcon
Argus Health
Mallinckrodt
Citi
Chubb
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot